Glenmark Pharmaceuticals Limited

Today, GLENMARK trades at 2,675.00 INR.

For broader market analysis, dive into the technicals on the Glenmark Pharmaceuticals Limited stock price chart and read the latest GLENMARK news:
– Buy Glenmark Pharma; target of Rs 3000: Motilal Oswal
– GLENMARK: Branded growth and specialty launches underpin H2 leverage and the FY27 cash outlook
– Glenmark Pharmaceuticals Q2 2027 Earnings Call Is Live

Markets don't sleep, here's what's going on with GLENMARK at the moment:
– Buy Glenmark Pharma; target of Rs 3000: Motilal Oswal
– GLENMARK: Branded growth and specialty launches underpin H2 leverage and the FY27 cash outlook
– Glenmark Pharmaceuticals Q2 2027 Earnings Call Is Live

See more updates in real-time with our News Flow.

Glenmark Pharmaceuticals Limited is scheduled to release its next earnings report on Feb 5, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts

GLENMARK stock is 2.05% volatile and has beta coefficient of 0.69.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like GLENMARK are typically less volatile than smaller companies

Track every detail on Glenmark Pharmaceuticals Limited stock chart and check out the list of the most volatile stocks — is Glenmark Pharmaceuticals Limited there?

To understand the GLENMARK stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — +3.27%
– 1 week — +16.28%
– 1 month — +21.68%

GLENMARK all-time low was 19.65 INR (Nov 5, 2003), and its highest price is 2,713.75 INR (Nov 9, 2026). Find more dynamics in the Stock Heatmap and on the Glenmark Pharmaceuticals Limited stock chart.

Glenmark Pharmaceuticals Limited market capitalization is ‪756.33 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Glenmark Pharmaceuticals Limited stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Glenmark Pharmaceuticals Limited stacks up against other companies

The safest way to buy Glenmark Pharmaceuticals Limited stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade GLENMARK directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.

As of Nov 11, 2026, the company has ‪17.78 K‬ employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.

Investing in Glenmark Pharmaceuticals Limited depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Glenmark Pharmaceuticals Limited financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our GLENMARK technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — strong buy
– 1-month — strong buy

Combine fundamental and technical analysis for better results.

Glenmark Pharmaceuticals Limited stock ticker depends on the exchange where it’s listed. On the NSE, its primary exchange, Glenmark Pharmaceuticals Limited stocks trade under the symbol GLENMARK.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.

Glenmark Pharmaceuticals Limited revenue for the last quarter amounts to ‪42.47 B‬ INR despite the estimated figure of ‪41.10 B‬ INR. In the next quarter revenue is expected to reach ‪42.63 B‬ INR.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in Glenmark Pharmaceuticals Limited financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses

Yes, you can track Glenmark Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.

GLENMARK net income for the last quarter is ‪2.64 B‬ INR, while the quarter before that showed ‪4.83 B‬ INR of net income which accounts for −45.38% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Glenmark Pharmaceuticals Limited financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control

Glenmark Pharmaceuticals Limited does pay dividends, which are distributed semi-annually. The most recent dividend per share was 2.50 INR, with a trailing twelve-month (TTM) dividend yield of 0.19%.

Explore more details on Glenmark Pharmaceuticals Limited dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view

GLENMARK reached its all-time high of 2,713.75 INR on Nov 9, 2026. Its all-time low was 19.65 INR and was reached on Nov 5, 2003.

Explore the Glenmark Pharmaceuticals Limited stock price chart to see more price history, and discover companies reaching new all-time highs and lows.

Glenmark Pharmaceuticals Limited EBITDA is ‪33.01 B‬ INR, with an EBITDA margin of 23.67%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in Glenmark Pharmaceuticals Limited statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality